Sector revisions Perspective Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 11:49:53 2026-07-16 am EDT			5-day change	1st Jan Change
3.010 ^USD	-6.52%		-5.68%	+8.73%

Jul. 08	Perspective Therapeutics, Inc. Announces Executive Changes	CI
Jul. 08	Perspective Therapeutics Names Paul Lyne Chief Science Officer as Co-Founder Michael Schultz Moves to Advisory Role	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
PERSPECTIVE THERAPEUTICS, INC.		15
LONZA GROUP AG		23
REVOLUTION MEDICINES, INC.		22
IQVIA HOLDINGS INC.		19
BEONE MEDICINES AG		27
CELLTRION, INC.		24
ASCENDIS PHARMA A/S	-	18
MEDPACE HOLDINGS, INC.		12
EUROFINS SCIENTIFIC SE		14
ICON PUBLIC LIMITED COMPANY		16
ABIVAX		6
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		15
BIO-TECHNE CORPORATION		12
TEMPUS AI, INC.		16
APOGEE THERAPEUTICS, INC.		12
KYMERA THERAPEUTICS, INC.		21
PHARMARON BEIJING CO., LTD.		11
PRAXIS PRECISION MEDICINES, INC.		19
IONIS PHARMACEUTICALS, INC.		21
ALKERMES PLC		17
Average		17
Weighted average by Cap.		19